Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -6.1125.0212.211.4669.70

What is the latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS ?

The latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS is -6.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-6.11
Mar202425.02
Mar202312.21
Mar20221.46
Mar202169.70

How is Core EBITDA Growth of PAR DRUGS AND CHEMICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -6.11
Negative
Mar2024 25.02
104.91
Mar2023 12.21
736.30
Mar2022 1.46
-97.91
Mar2021 69.7 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare Core EBITDA Growth ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹111.0 Cr 8.4% -0.9% -9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,677.0 Cr -2.4% 6.4% 7% Stock Analytics
DIVIS LABORATORIES ₹180,458.0 Cr -0.9% 5% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹153,685.0 Cr 1.6% 7.6% 38.5% Stock Analytics
CIPLA ₹114,562.0 Cr 1.2% 7.7% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,095.0 Cr 0.1% -1.2% 8.7% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

8.4%

-0.9%

-9.3%

SENSEX

0.7%

-1%

-7%


You may also like the below Video Courses